Reunion of world's first AcrySof lens implant

Article

A twenty year reunion was held to commemorate the first monofocal AcrySof lens implant operation.

A twenty year reunion was held to commemorate the first monofocal AcrySof lens implant operation.

The procedure was performed by eye surgeon Richard Packard in 1990 on Nellie Diaper at the King Edward VII Hospital in Windsor, UK.

Mr Packard, senior surgeon at the Prince Charles Eye Unit in Windsor and director and consultant ophthalmic surgeon at Arnott Eye Associates, said: “At the time of Nellie’s original operation I had no idea it was going to be momentous. The material was unlike anything I’d ever used before. We were more used to working with silicone rubber and rigid plastic implants in cataract surgery than this new material, which felt sticky and was initially awkward to handle. The lens implanted in Mrs Diaper’s eye was monofocal and the surgery was routine. At the time none of us thought of it as being revolutionary; it was just the start of a clinical trial.”

AcrySof lens is made from a hydrophobic acrylic substance and has been the basis of cataract treatment for 55 million patients over the last 20 years. The lens can be inserted in an incision of approximately 2 mm and has an extremely low level of secondary intervention.

For more information visit www.alconlabs.com/gb or www.acrysofrestor.com

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.